<!DOCTYPE html>
<html>
    <head>
    <title>§ 44-109.02 Pre-admission medication management assessment.</title>
        <meta http-equiv='content-type' content='text/html; charset=utf-8' />
    </head>
    <body>
        <h1>§ 44-109.02 Pre-admission medication management assessment.</h1>
        
            
                <p>Within 30 days prior to admission, the ALR shall consult with the prospective resident's healthcare practitioner regarding:</p>
            
        

        
        <dl>
            
                <dt>1</dt>
                <dd> The prospective resident's current medication profile, including a review of nonprescription drugs;</dd>
            
                <dt>2</dt>
                <dd> Possible adverse interactions;</dd>
            
                <dt>3</dt>
                <dd> Common expected or unexpected side effects; and</dd>
            
                <dt>4</dt>
                <dd> The potential that such medications have to act as chemical restraints.</dd>
            
        </dl>
        

        
        <h3>Historical and Statutory</h3>
        <p>Legislative History of Laws

For Law 13-127, see notes following § 44-101.01.

DC CODE § 44-109.02

Current through December 11, 2012</p>
        

        
        <h3>Credits</h3>
        <p>(June 24, 2000, D.C. Law 13-127, § 902, 47 DCR 2647.)</p>
        
    </body>
</html>
